New Key Statistics Module, Z-Score and F-Score
NAS:AYTU Key Ratios
| Market Cap $ M | 17.87 |
| Enterprise Value $ M | 13.77 |
| P/E(ttm) | -- |
| PE Ratio without NRI | -- |
| Forward PE Ratio | 6.42 |
| Price/Book | 0.54 |
| Price/Sales | 0.15 |
| Price/Free Cash Flow | 2.24 |
| Price/Owner Earnings | -- |
| Payout Ratio % | -- |
| Revenue (TTM) $ M | 98.00 |
| EPS (TTM) $ | -4.04 |
| Beneish M-Score | -2.85 |
| 10-y EBITDA Growth Rate % | -- |
| 5-y EBITDA Growth Rate % | 77.30 |
| y-y EBITDA Growth Rate % | -- |
| EV-to-EBIT | -2.45 |
| EV-to-EBITDA | 4.45 |
| PEG | -- |
| Shares Outstanding M | 5.57 |
| Net Margin (%) | -18.27 |
| Operating Margin % | -5.71 |
| Pre-tax Margin (%) | -17.43 |
| Quick Ratio | 0.91 |
| Current Ratio | 1.11 |
| ROA % (ttm) | -13.06 |
| ROE % (ttm) | -47.09 |
| ROIC % (ttm) | -6.67 |
| Dividend Yield % | -- |
| Altman Z-Score | -2.84 |
AYTU Number of Guru Trades
AYTU Volume of Guru Trades
Gurus Latest Trades with NAS:AYTU
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
NAS:AYTU is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Aytu BioPharma Inc Insider Transactions
No Available Data
News about NAS:AYTU
Total 0- 1
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers